Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.76 USD | +1.05% | +4.14% | +21.39% |
May. 22 | Halozyme Therapeutics Insider Sold Shares Worth $905,480, According to a Recent SEC Filing | MT |
May. 07 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.39% | 5.64B | |
+14.15% | 118B | |
+12.67% | 106B | |
-3.96% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-17.90% | 15.56B | |
+4.09% | 13.63B | |
+28.02% | 12.27B |
- Stock Market
- Equities
- HALO Stock
- News Halozyme Therapeutics, Inc.
- Health Care Stocks Hanging On For Slim Gains